Logo

American Heart Association

  2
  0


Final ID:

Panel

  • Harrington, Katherine  ( The Heart Hospital Baylor Plano , Plano , Texas , United States )
  • Grubb, Kendra  ( Emory University , Atlanta , Georgia , United States )
  • Mehran, Roxana  ( Icahn School of Med. at Mount Sinai , New York , New York , United States )
  • Al-kazaz, Mohamed  ( Northwestern University , Chicago , Illinois , United States )
  • Author Disclosures:
    Katherine Harrington: No Answer | Kendra Grubb: DO have relevant financial relationships ; Speaker:Medtronic:Active (exists now) ; Advisor:Ancora:Active (exists now) ; Consultant:4C Medical:Active (exists now) ; Consultant:Boston Scientific:Past (completed) ; Consultant:Abbott:Past (completed) ; Consultant:Medtronic:Active (exists now) | ROXANA MEHRAN: DO have relevant financial relationships ; Consultant:Abbott, Affluent Medical, Alleviant Medical, Amgen, AstraZeneca, BAIM, Beth Israel Deaconess Medical Center, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CERC, Chiesi, Concept Medical, Daiichi Sankyo, Duke, Faraday, Idorsia, Janssen, MedAlliance, Medscape, Mediasphere, Medtelligence, Medtronic, Novartis, OrbusNeich, Pi-Cardia, Protembis, RM Global Bioaccess Fund Management, Sanofi:Active (exists now) ; Advisor:AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program):Active (exists now) ; Other (please indicate in the box next to the company name):SCAI (Women in Innovations Committee Member), Faculty CRF, Women as One:Active (exists now) ; Individual Stocks/Stock Options:Elixir Medical, Stel, ControlRad (spouse):Active (exists now) ; Speaker:Affluent Medical, Boehringer Ingelheim, Chiesi USA, Cordis, Esperion Science/Innovative Biopharma, Gaffney Events, Educational Trust, Global Clinical Trial Partners, Ltd., IQVIA, Medscape/WebMD Global, NovoNordisk, PeerView Institute for Medical Education, TERUMO Europe N.V., Radcliffe:Active (exists now) | Mohamed Al-Kazaz: DO have relevant financial relationships ; Consultant:Kiniksa pharmaceuticals.:Active (exists now) ; Consultant:Edward Lifesciences:Past (completed) ; Researcher:Kiniksa pharmaceuticals.:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

How Soon is Too Soon: A New Paradigm for the Preventive Management of Aortic Stenosis

Saturday, 11/16/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Asymptomatic Severe AS: Why Wait Until it’s too Late?

Genereux Philippe, Dweck Marc

Moderate AS: No Longer of Moderate Significance?

Van Mieghem Nicolas, Delgado Victoria

More abstracts from these authors:
Case Presentation of Asymptomatic Aortic Stenosis

Hamilton Barbara, Chung Jennifer, Chen Lilyanne, Harrington Katherine

Panel Discussion

Van Mieghem Nicolas, Chikwe Joanna, Skelding Kimberly, Mehran Roxana, Al-kazaz Mohamed

You have to be authorized to contact abstract author. Please, Login
Not Available